Hannah Mamuszka's Contact Details

Hannah Mamuszka's Company Details

ALVA10

Boston, MA, US • 5 - 9 Employees
BioTech/Drugs

Our business model restructures the relationship between payers, employers, and diagnostic companies, creating partnerships instead of adversaries. The result of this new way of doing business is a broad range of completely novel healthcare tools (diagnostics, devices, apps) that directly solve the largest clinical and economic challenges for payers and providers. We enable our payer/provider/employer partners to source innovations for their greatest needs directly from us. And our industry-leading asset of Precision Medicine technology curation ensures that those partners receive the best-in-class tool for their particular problem. We partner payers and employers with diagnostic and technology companies to solve the greatest challenges of both parties. By facilitating the process by which technology companies design fit-for-purpose solutions for payers and providers, technology companies' greatest commercial challenges are also alleviated, as payers and employers become partners to ‘pull' new technology into the market. In this time of healthcare technology advances, the scientific challenge is no longer the greatest hurdle. Patient access, provider confidence, and payer approval are the critical components of a successful go-to-market approach. By aligning incentives, together we can bring new tools to market to optimize patient care and reduce healthcare spend. We also work with investors in the healthcare space, to allow them to assess commercial readiness of emerging technologies and determine commercial viability.